Journal
DISEASE MODELS & MECHANISMS
Volume 5, Issue 1, Pages 26-32Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.008268
Keywords
-
Categories
Funding
- California Institute for Regenerative Medicine
- CIRM [RL1-00649-1]
- Lookout and Mathers Foundation
- Helmsley Foundation
- Sanofi-Aventis
Ask authors/readers for more resources
Psychiatric disorders, including autism spectrum disorders and schizophrenia, are extremely heritable complex genetic neurodevelopmental disorders. It is now possible to directly reprogram fibroblasts from psychiatric patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiate these disorder-specific hiPSCs into neurons. This means that researchers can generate nearly limitless quantities of live human neurons with genetic backgrounds that are known to result in psychiatric disorders, without knowing which genes are interacting to produce the disease state in each patient. With these new human-cell-based models, scientists can investigate the precise cell types that are affected in these disorders and elucidate the cellular and molecular defects that contribute to disease initiation and progression. Here, we present a short review of experiments using hiPSCs and other sophisticated in vitro approaches to study the pathways underlying psychiatric disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available